NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACETAMINOPHEN | ACETAMINOPHEN | GERI-CARE PHARMACEUTICAL CORP | 92c22593-daf9-20a8-e053-2a95a90a365d | 2024-07-23 | Warnings | 362O9ITL9D |
| Cold plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION, INC. | 4872dfdd-0df6-47ae-87f2-8049191cd482 | 2024-07-18 | Warnings | 362O9ITL9D |
| pain relief pm extra strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Publix Super Markets Inc | 42d271b7-b45f-4497-8de2-4e05b4bebfa9 | 2024-07-17 | Warnings | M013 362O9ITL9D |
| basic care acetaminophen pm | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Amazon.com Services LLC | 64a0084a-e29e-4c1a-8704-13a3e1238f76 | 2024-07-17 | Warnings | M013 362O9ITL9D |
| Mucus Relief Cold Flu Sore Throat Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Walgreens | 04defcf6-e20e-402b-b725-d9394a0146b1 | 2024-07-16 | Warnings | 362O9ITL9D |
| Low Dose Aspirin | ASPIRIN | Walmart Inc. | 152c013a-c81c-f8f9-e063-6294a90a9f23 | 2024-07-15 | Warnings | M013 |
| Basic Care severe cold and cough | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE | Amazon.com Services LLC | 924bf427-b054-46af-b341-ff162946cd58 | 2024-07-15 | Warnings | 362O9ITL9D |
| Maximum Strength Cold Tabs | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | JHK DBA American Safety & First Aid | e7d4fe9a-eb09-4266-90c9-290f61ce6ad0 | 2024-07-15 | Warnings | 362O9ITL9D |
| Nighttime severe cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | TARGET CORPORATION | 1cf3064d-4ddd-63b9-e063-6294a90aa547 | 2024-07-11 | Warnings | 362O9ITL9D |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | NuCare Pharmaceuticals, Inc. | 5411544e-3c2d-4e42-e054-00144ff8d46c | 2024-07-10 | Warnings | M013 |
| good sense pain relief pm extra strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | L. Perrigo Company | b97c51ad-4953-4491-9ceb-395550eb5296 | 2024-07-10 | Warnings | M013 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walgreens | 065e6f1b-f68c-491a-a157-84961a07e3d9 | 2024-07-10 | Warnings | M013 362O9ITL9D |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walgreens | 3b7b6725-2996-44d3-89a3-032384e7e2ce | 2024-07-10 | Warnings | M013 362O9ITL9D |
| equate pain and fever infants | ACETAMINOPHEN | Wal-Mart Stores Inc | 8a152c8d-8ae0-4201-8bb9-7b22c3577415 | 2024-07-10 | Warnings | M013 362O9ITL9D |
| Daytime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HCL | TARGET CORPORATION | 1ccbdb53-3f70-28da-e063-6394a90a9ae0 | 2024-07-09 | Warnings | 362O9ITL9D |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | WinCo Foods, LLC | 3c57498c-86b0-4ba3-881e-c742a2e8ece5 | 2024-07-09 | Warnings | M013 362O9ITL9D |
| Acetaminophen Extra Strength | ACETAMINOPHEN | WinCo Foods, LLC | c358d1dd-9fcb-4d18-9521-8f898b98a732 | 2024-07-09 | Warnings | M013 362O9ITL9D |
| Acetaminophen Regular Strength | ACETAMINOPHEN | WinCo Foods, LLC | 15430025-f25e-4fe7-b1fe-4eda4684081a | 2024-07-09 | Warnings | M013 313782 362O9ITL9D |
| Acetaminophen Easy Tabs Extra Strength | ACETAMINOPHEN | WinCo Foods, LLC | 0631f003-4852-4034-a1c5-1552804b1660 | 2024-07-09 | Warnings | M013 362O9ITL9D |
| Aspirin Low Dose | ASPIRIN | Bryant Ranch Prepack | 61ecf3c9-42fa-4ae4-bd3b-694090477b9a | 2024-07-09 | Warnings | M013 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.